RB1 and neoplasm: Here, by using a previously reported in vitro model of gliomagenesis [12], we tested the hypothesis that defined changes in the expression of a proto-oncogene (Ras) and a tumor suppressor (Rb) confer tumor cells the ability to avoid immune destruction.